They signed a “right of first refusal,” wherein Pfizer will get the first shot at OTC rights for Rhinocort Aqua, a glucocorticosteroid for non-infectious rhinitis. This evidence demonstrates that intranasal and inhaled budesonide, the…
kavita sangrah
They signed a “right of first refusal,” wherein Pfizer will get the first shot at OTC rights for Rhinocort Aqua, a glucocorticosteroid for non-infectious rhinitis. This evidence demonstrates that intranasal and inhaled budesonide, the…